| [1] | Buonfrate D, Ferrari TCA, Adegnika AA, et al. Human schistosomiasis[J]. Lancet, 2025, 405(10479): 658-670. | | [2] | LoVerde PT. Schistosomiasis[J]. Adv Exp Med Biol, 2024, 1454: 75-105. | | [3] | 钟昊然, 金亚美. 日本血吸虫病肝纤维化的研究进展[J]. 中国动物传染病学报, 2023, 31(6): 177-183. | | | Zhong HR, Jin YM. Advance on liver fibrosis induced by Schistosoma japonicum infection[J]. Chin J Vet Parasitol, 2023, 31(6): 177-183. (in Chinese) | | [4] | 何君逸, 张利娟, 杨帆, 等. 2024年全国血吸虫病防治进展[J]. 中国血吸虫病防治杂志(中英文), 2025, 37(3): 223-231. | | | He JY, Zhang LJ, Yang F, et al. Progress of schistosomiasis control in the people’s republic of China in 2024[J]. Chin J Schisto Control, 2025, 37(3): 223-231. (in Chinese) | | [5] | Liu ZL, Zhang LC, Liang YM, et al. Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis[J]. Front Cell Infect Microbiol, 2022, 12: 1035765. | | [6] | Marconi GD, Fonticoli L, Rajan TS, et al. Epithelial-mesenchymal transition (EMT): the type-2 EMT in wound healing, tissue regeneration and organ fibrosis[J]. Cells, 2021, 10(7): 1587. | | [7] | Zhu W, Zhu ZX, Feng J, et al. PRAG1 promotes cholangiocyte epithelial-mesenchymal transition and liver fibrosis in biliary atresia[J]. Biochim Biophys Acta Mol Basis Dis, 2025, 1871(8): 167994. | | [8] | Chu AS, Diaz R, Hui JJ, et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis[J]. Hepatology, 2011, 53(5): 1685-1695. | | [9] | Chen J, Ge SJ, Feng HJ, et al. KRT17 promotes the activation of HSCs via EMT in liver fibrosis[J]. J Clin Transl Hepatol, 2022, 10(2): 207-218. | | [10] | McManus DP, Bergquist R, Cai PF, et al. Schistosomiasis―from immunopathology to vaccines[J]. Semin Immunopathol, 2020, 42(3): 355-371. | | [11] | Perera DJ, Koger-Pease C, Paulini K, et al. Beyond schistosomiasis: unraveling co-infections and altered immunity[J]. Clin Microbiol Rev, 2024, 37(1): e00098-e00023. | | [12] | Sisto M, Ribatti D, Lisi S. Organ fibrosis and autoimmunity: the role of inflammation in TGFβ-dependent EMT[J]. Biomolecules, 2021, 11(2): 310. | | [13] | Kumar V, Xin XF, Ma JY, et al. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis[J]. Adv Drug Deliv Rev, 2021, 176: 113888. | | [14] | Zhang XX, Chen JC, Lin RH, et al. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway[J]. Redox Biol, 2024, 75: 103246. | | [15] | Li MD, Chen LH, Xiang HX, et al. Benzo [a] pyrene evokes epithelial-mesenchymal transition and pulmonary fibrosis through AhR-mediated Nrf2-p62 signaling[J]. J Hazard Mater, 2024, 473: 134560. | | [16] | Shu GW, Yusuf A, Dai CX, et al. Piperine inhibits AML-12 hepatocyte EMT and LX-2 HSC activation and alleviates mouse liver fibrosis provoked by CCl(4): roles in the activation of the Nrf2 cascade and subsequent suppression of the TGF-β1/Smad axis[J]. Food Funct, 2021, 12(22): 11686-11703. | | [17] | Kong C, Qu XZ, Liu MM, et al. Dynamic interactions between E-cadherin and Ankyrin-G mediate epithelial cell polarity maintenance[J]. Nat Commun, 2023, 14(1): 6860. | | [18] | Nakagawa H, Hikiba Y, Hirata Y, et al. Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis[J]. Proc Natl Acad Sci USA, 2014, 111(3): 1090-1095. | | [19] | Jiang TT, Wu XY, Zhou H, et al. Pathological changes in hepatic sinusoidal endothelial cells in Schistosoma japonicum-infected mice[J]. Trop Med Infect Dis, 2023, 8(2): 124. | | [20] | So RJ, Collins SL, Chan-Li Y, et al. Localized knockout of E-cadherin in subglottic mucosa increases fibrosis[J]. Otolaryngol Head Neck Surg, 2025, 172(6): 2003-2008. | | [21] | Peng DD, Fu MY, Wang MN, et al. Targeting TGF-β signal transduction for fibrosis and cancer therapy[J]. Mol Cancer, 2022, 21(1): 104. | | [22] | Zhang CY, Zhang Y, Hu X, et al. Luteolin inhibits subretinal fibrosis and epithelial-mesenchymal transition in laser-induced mouse model via suppression of Smad2/3 and YAP signaling[J]. Phytomedicine, 2023, 116: 154865. | | [23] | Lee JH, Massagué J. TGF-β in developmental and fibrogenic EMTs[J]. Semin Cancer Biol, 2022, 86(Pt 2): 136-145. |
|